Literature DB >> 31728756

Liver-derived FGF21 is essential for full adaptation to ketogenic diet but does not regulate glucose homeostasis.

Mikiko Watanabe1,2, Garima Singhal1, Ffolliott M Fisher1, Thomas C Beck3, Donald A Morgan4, Fabio Socciarelli5, Marie L Mather1, Renata Risi2, Jared Bourke1, Kamal Rahmouni4, Owen P McGuinness3, Jeffrey S Flier1,6, Eleftheria Maratos-Flier7.   

Abstract

BACKGROUND: Fibroblast growth factor 21 (FGF21) is expressed in several metabolically active tissues, including liver, fat, and acinar pancreas, and has pleiotropic effects on metabolic homeostasis. The dominant source of FGF21 in the circulation is the liver. OBJECTIVE AND METHODS: To analyze the physiological functions of hepatic FGF21, we generated a hepatocyte-specific knockout model (LKO) by mating albumin-Cre mice with FGF21 flox/flox (fl/fl) mice and challenged it with different nutritional models.
RESULTS: Mice fed a ketogenic diet typically show increased energy expenditure; this effect was attenuated in LKO mice. LKO on KD also developed hepatic pathology and altered hepatic lipid homeostasis. When evaluated using hyperinsulinemic-euglycemic clamps, glucose infusion rates, hepatic glucose production, and glucose uptake were similar between fl/fl and LKO DIO mice.
CONCLUSIONS: We conclude that liver-derived FGF21 is important for complete adaptation to ketosis but has a more limited role in the regulation of glycemic homeostasis.

Entities:  

Keywords:  Adipose tissue; Cholesterol; Energy metabolism; Fibroblast Growth Factor 21; Ketogenic diet; Nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2019        PMID: 31728756      PMCID: PMC7948212          DOI: 10.1007/s12020-019-02124-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  54 in total

1.  Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.

Authors:  Takashi Shimada; Yuji Yamazaki; Motoo Takahashi; Hisashi Hasegawa; Itaru Urakawa; Takeshi Oshima; Kaori Ono; Makoto Kakitani; Kazuma Tomizuka; Toshiro Fujita; Seiji Fukumoto; Takeyoshi Yamashita
Journal:  Am J Physiol Renal Physiol       Date:  2005-07-05

2.  Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse.

Authors:  Julio E Ayala; Deanna P Bracy; Owen P McGuinness; David H Wasserman
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

3.  Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.

Authors:  Ffolliott M Fisher; Patricia C Chui; Patrick J Antonellis; Holly A Bina; Alexei Kharitonenkov; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461

4.  Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.

Authors:  Ffolliott M Fisher; Patricia C Chui; Imad A Nasser; Yury Popov; Jeremy C Cunniff; Thomas Lundasen; Alexei Kharitonenkov; Detlef Schuppan; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Gastroenterology       Date:  2014-07-30       Impact factor: 22.682

5.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

Authors:  Michael K Badman; Pavlos Pissios; Adam R Kennedy; George Koukos; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

Review 6.  FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties.

Authors:  Alexei Kharitonenkov; Richard DiMarchi
Journal:  Trends Endocrinol Metab       Date:  2015-10-18       Impact factor: 12.015

7.  Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.

Authors:  Kathleen R Markan; Meghan C Naber; Magdalene K Ameka; Maxwell D Anderegg; David J Mangelsdorf; Steven A Kliewer; Moosa Mohammadi; Matthew J Potthoff
Journal:  Diabetes       Date:  2014-07-09       Impact factor: 9.461

8.  Fibroblast growth factor 21 has no direct role in regulating fertility in female mice.

Authors:  Garima Singhal; Nicholas Douris; Alan J Fish; Xinyao Zhang; Andrew C Adams; Jeffrey S Flier; Pavlos Pissios; Eleftheria Maratos-Flier
Journal:  Mol Metab       Date:  2016-05-18       Impact factor: 7.422

9.  Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury.

Authors:  Bhavna N Desai; Garima Singhal; Mikiko Watanabe; Darko Stevanovic; Thomas Lundasen; Ffolliott M Fisher; Marie L Mather; Hilde G Vardeh; Nicholas Douris; Andrew C Adams; Imad A Nasser; Garret A FitzGerald; Jeffrey S Flier; Carsten Skarke; Eleftheria Maratos-Flier
Journal:  Mol Metab       Date:  2017-08-19       Impact factor: 7.422

10.  Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet.

Authors:  Garima Singhal; Gaurav Kumar; Suzanne Chan; Ffolliott M Fisher; Yong Ma; Hilde G Vardeh; Imad A Nasser; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Mol Metab       Date:  2018-03-08       Impact factor: 7.422

View more
  13 in total

1.  LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia.

Authors:  Daniel J Rader; Eleftheria Maratos-Flier; Amanda Nguyen; Doug Hom; Michael Ferriere; Yifang Li; Jill Kompa; Miljen Martic; Markus Hinder; Craig T Basson; David Yowe; John Diener; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

2.  Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease.

Authors:  Vera Karamfilova; Yavor Assyov; Iveta Nedeva; Antoaneta Gateva; Irena Ivanova; Ivanova Cherkezov; Ludmila Mateva; Zdravko Kamenov
Journal:  Turk J Gastroenterol       Date:  2022-03       Impact factor: 1.555

3.  Do Lower-Carbohydrate Diets Increase Total Energy Expenditure? An Updated and Reanalyzed Meta-Analysis of 29 Controlled-Feeding Studies.

Authors:  David S Ludwig; Stephanie L Dickinson; Beate Henschel; Cara B Ebbeling; David B Allison
Journal:  J Nutr       Date:  2021-03-11       Impact factor: 4.798

Review 4.  Roles of Fibroblast Growth Factors and Their Therapeutic Potential in Treatment of Ischemic Stroke.

Authors:  Confidence Dordoe; Keyang Chen; Wenting Huang; Jun Chen; Jian Hu; Xue Wang; Li Lin
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

5.  Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.

Authors:  Mikiko Watanabe; Renata Risi; Elisabetta Camajani; Savina Contini; Agnese Persichetti; Dario Tuccinardi; Ilaria Ernesti; Stefania Mariani; Carla Lubrano; Alfredo Genco; Giovanni Spera; Lucio Gnessi; Sabrina Basciani
Journal:  Nutrients       Date:  2020-07-18       Impact factor: 5.717

6.  Deletion of KLF10 Leads to Stress-Induced Liver Fibrosis upon High Sucrose Feeding.

Authors:  Junghoon Lee; Ah-Reum Oh; Hui-Young Lee; Young-Ah Moon; Ho-Jae Lee; Ji-Young Cha
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

Review 7.  Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature.

Authors:  Mikiko Watanabe; Rossella Tozzi; Renata Risi; Dario Tuccinardi; Stefania Mariani; Sabrina Basciani; Giovanni Spera; Carla Lubrano; Lucio Gnessi
Journal:  Obes Rev       Date:  2020-03-24       Impact factor: 9.213

8.  Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma.

Authors:  Takumi Kawaguchi; Sachiyo Yoshio; Yuzuru Sakamoto; Ryuki Hashida; Shunji Koya; Keisuke Hirota; Dan Nakano; Sakura Yamamura; Takashi Niizeki; Hiroo Matsuse; Takuji Torimura
Journal:  J Clin Med       Date:  2020-03-28       Impact factor: 4.241

Review 9.  Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review.

Authors:  Mikiko Watanabe; Renata Risi; Davide Masi; Alessandra Caputi; Angela Balena; Giovanni Rossini; Dario Tuccinardi; Stefania Mariani; Sabrina Basciani; Silvia Manfrini; Lucio Gnessi; Carla Lubrano
Journal:  Nutrients       Date:  2020-09-20       Impact factor: 5.717

10.  Comparison of Ketogenic Diets with and without Ketone Salts versus a Low-Fat Diet: Liver Fat Responses in Overweight Adults.

Authors:  Christopher D Crabtree; Madison L Kackley; Alexandru Buga; Brandon Fell; Richard A LaFountain; Parker N Hyde; Teryn N Sapper; William J Kraemer; Debbie Scandling; Orlando P Simonetti; Jeff S Volek
Journal:  Nutrients       Date:  2021-03-17       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.